Dr Reddys Laboratories News

Dr. Reddy's Laboratories Limited, which makes and packages over-the-counter and prescription medicine, plans to expand its Shreveport operations.

BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Qwest Communications , Bunge Limited , Cephalon , Dr.

David Gardner called it. He's up 1,334%! See what David's recommending that you buy NEXT.

As global markets come back from their depths, one country that's looking up is India.

If you think the U.S. market has had a torrid run this year, take a look at India.

Dr Reddy's Laboratories has succeeded in developing a copycat or generic version of Pfizer's Lipitor, the world's largest selling drug which has sales of over $10 billion.

The Dow rose 0.8% and regained its 50-day moving average. But the blue-chip index was up as much as 1.5% and down as much as 0.3%. Meanwhile, the NYSE composite and S&P 500 climbed 0.7% and 0.6% respectively.

The top dogs of the recent uptrend capitulated last week as the broad market took a beating.

Generic drug maker Dr. Reddy's Laboratories reported on Oct. 23 a doubling of net profit in the second quarter, aided by the launch of new drugs in overseas markets.

HYDERABAD: Dr. Reddy's Laboratories has described the reports on its take over by pharma major GlaxoSmithKline as "speculative". DRL Vice-President and Chief Executive Officer G. V. Prasad said the company had entered into a strategic tie-up with the GSK for marketing its products in the emerging markets.

Hyderabad-based pharmaceutical major Dr Reddy's Laboratories Ltd more than doubled its net profit to Rs 217 crore during the July-September quarter compared to Rs 105 crore in the same period last year, its consolidated results announced today show.

Revenues, including forex gain of Rs 24 crore, during the quarter touched Rs 1,836.8 crore, against Rs 1,615.1 crore, reflecting an increase of 14%. EPS stood at Rs 12 in Q2 FY10 as against Rs 6 in Q2 FY09.

Partners Biogen Idec and Elan Corp. led drug stocks lower early Friday as shares of the companies fell on news that European regulators were reviewing the safety of their multiple sclerosis drug Tysabri.

Hyderabad, Oct 20 : Dr Reddy's Laboratories Limited today announced that it has joined the Green Chemistry Institute Pharmaceutical Roundtable of the American Chemical Society as an Associate member.

Western drugmakers are stepping up the hunt for emerging market "tigers" in India.

New York: Indian stocks trading on American bourses gained nearly USD 4 billion last week, with IT major Wipro and private sector lender ICICI Bank pocketing most of the gains.

Pharmaceutical Major, Lupin Ltd. announced today the acquisition of US rights for Antara .

Dr Reddy's Laboratories has recalled some batches of four products from its key US market that were observed to contain some oversized tablets.

Janssen battled a gaggle of generic drug makers over "a method for treating Alzheimer's disease with galanthamine." The patent of contention was 4,663,318 . The issue before the courts was enablement , which, on appeal, the CAFC majority tied to utility for instant determination.

Indian stocks trading on American bourses lost over USD 1 billion last week, with IT bellwether Infosys accounting for most of the losses.